Pet Pharm Biotech Co., Ltd. (TPEX:7762)

Taiwan · Delayed Price · Currency is TWD

56.00

-0.50 (-0.88%)

At close: Sep 10, 2026

Pet Pharm Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	2,355	3,585	1,656	-	-
Market Cap Growth	-41.25%	116.51%	-	-	-
Enterprise Value	2,235	3,187	1,535	-	-
Last Close Price	56.50	68.62	38.70	-	-

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
PE Ratio	109.68	143.47	114.14	-	-
PS Ratio	8.87	16.14	12.67	-	-
PB Ratio	2.02	3.00	2.84	-	-
P/TBV Ratio	2.19	3.32	2.89	-	-
P/FCF Ratio	53.27	748.49	-	-	-
P/OCF Ratio	34.05	104.52	57.32	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
EV/Sales Ratio	8.42	14.35	11.75	-	-
EV/EBITDA Ratio	33.53	83.45	78.93	-	-
EV/EBIT Ratio	98.80	216.15	189.22	-	-
EV/FCF Ratio	50.55	665.45	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Debt / Equity Ratio	0.09	0.09	0.25	0.12	0.32
Debt / EBITDA Ratio	1.62	2.22	5.45	1.99	4.53
Debt / FCF Ratio	2.45	22.17	-	5.97	-
Net Debt / Equity Ratio	-0.26	-0.34	-0.42	-0.29	0.19
Net Debt / EBITDA Ratio	-5.50	-10.81	-12.55	-6.41	4.38
Net Debt / FCF Ratio	-6.83	-86.18	1.53	-14.89	-0.92
Asset Turnover	0.22	0.21	0.21	0.35	-
Inventory Turnover	11.30	7.46	4.96	6.42	-
Quick Ratio	5.77	10.28	3.01	6.18	1.94
Current Ratio	6.03	10.68	3.16	10.97	5.05
Return on Equity (ROE)	2.88%	2.80%	2.91%	3.34%	-
Return on Assets (ROA)	1.16%	0.88%	0.81%	1.40%	-
Return on Capital Employed (ROCE)	1.80%	1.10%	1.30%	1.70%	-2.80%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Earnings Yield	1.27%	0.70%	0.88%	-	-
FCF Yield	1.88%	0.13%	-9.63%	-	-
Dividend Yield	0.51%	0.36%	0.23%	-	-
Payout Ratio	16.83%	20.22%	55.42%	-	-
Buyback Yield / Dilution	-23.02%	-32.26%	-37.19%	-19.84%	-
Total Shareholder Return	-22.51%	-31.90%	-36.96%	-19.84%	-